An observational study to evaluate AZD9291 treatment in patients with T790M positive non-small cell lung cancer

Trial Identifier: D5160R00021
Sponsor:AstraZeneca
NCTID:NCT03457220
Start Date:June 2018
Primary Completion Date: December 2019
Study Completion Date: December 2019
Condition: Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

CountryLocation
Taiwan Kaohsiung, Taiwan, 83301
Taiwan Kaohsiung, Taiwan, 807
Taiwan Taichung, Taiwan, 40705
Taiwan Tainan City, Taiwan, 73657
Taiwan Tainan City, Taiwan, 70403
Taiwan Taipei, Taiwan, 10002
Taiwan Taipei, Taiwan, 112